HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

E Briasoulis Selected Research

Fluorouracil (Carac)

11/2005Postoperative dose-dense sequential chemotherapy with epirubicin, followed by CMF with or without paclitaxel, in patients with high-risk operable breast cancer: a randomized phase III study conducted by the Hellenic Cooperative Oncology Group.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


E Briasoulis Research Topics

Disease

25Neoplasms (Cancer)
08/2015 - 01/2000
17Breast Neoplasms (Breast Cancer)
11/2012 - 01/2000
5Carcinoma (Carcinomatosis)
07/2008 - 09/2000
4Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
01/2011 - 03/2004
4Neoplasm Metastasis (Metastasis)
07/2008 - 09/2000
4Neutropenia
12/2007 - 01/2000
3Melanoma (Melanoma, Malignant)
04/2012 - 01/2002
2Febrile Neutropenia
12/2007 - 10/2004
2Small Cell Lung Carcinoma (Small Cell Lung Cancer)
12/2007 - 11/2005
2Vomiting
05/2005 - 01/2002
2Fatigue
01/2004 - 01/2002
2Hypersensitivity (Allergy)
01/2002 - 07/2000
2Pulmonary Edema
01/2001 - 01/2000
1Hypoxia (Hypoxemia)
08/2015
1Colorectal Neoplasms (Colorectal Cancer)
12/2012
1B-Cell Lymphoma (Lymphoma, B Cell)
10/2012
1Lymphoma (Lymphomas)
10/2012
1Thrombocytopenia (Thrombopenia)
05/2008
1Ovarian Epithelial Carcinoma
09/2007
1Ovarian Neoplasms (Ovarian Cancer)
01/2006
1Diarrhea
02/2005
1Exanthema (Rash)
02/2005
1Mouth Neoplasms (Oral Cancer)
01/2005
1Hyponatremia
01/2005
1Inappropriate ADH Syndrome (SIADH)
01/2005
1Venous Thrombosis (Deep-Vein Thrombosis)
10/2004
1Anorexia
01/2004

Drug/Important Bio-Agent (IBA)

7Paclitaxel (Taxol)FDA LinkGeneric
11/2012 - 09/2000
6Proteins (Proteins, Gene)FDA Link
01/2012 - 09/2001
5Irinotecan (Camptosar)FDA LinkGeneric
12/2012 - 09/2004
4Docetaxel (Taxotere)FDA Link
11/2012 - 01/2000
4ParaffinIBA
12/2008 - 04/2003
4Cisplatin (Platino)FDA LinkGeneric
12/2007 - 05/2005
4PlatinumIBA
01/2006 - 09/2003
3Vinorelbine (Navelbine)FDA LinkGeneric
08/2015 - 09/2001
3Biomarkers (Surrogate Marker)IBA
11/2012 - 04/2012
3taxaneIBA
11/2012 - 05/2008
3Estrogen ReceptorsIBA
01/2012 - 09/2001
3AnthracyclinesIBA
05/2009 - 09/2001
3Epirubicin (Ellence)FDA LinkGeneric
05/2008 - 10/2004
3Granulocyte Colony-Stimulating Factor (G-CSF)IBA
12/2007 - 01/2000
3beta-D-glucosylisophosphoramide mustard (glufosfamide)IBA
03/2004 - 10/2000
2DNA (Deoxyribonucleic Acid)IBA
08/2015 - 10/2012
2Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
12/2012 - 01/2006
2Taxoids (Taxanes)IBA
11/2012 - 07/2000
2Messenger RNA (mRNA)IBA
04/2012 - 12/2008
2Thrombospondin 1IBA
01/2012 - 01/2006
2ErbB Receptors (EGF Receptor)IBA
01/2011 - 02/2005
2Formaldehyde (Formol)FDA Link
12/2008 - 12/2004
2Gefitinib (Iressa)FDA Link
12/2007 - 02/2005
2Etoposide (VP 16)FDA LinkGeneric
12/2007 - 11/2005
2MetallothioneinIBA
01/2006 - 04/2003
2Carboplatin (JM8)FDA LinkGeneric
10/2004 - 09/2000
2Proliferating Cell Nuclear Antigen (PCNA)IBA
05/2004 - 04/2003
2Pharmaceutical PreparationsIBA
03/2004 - 01/2001
2Interleukin-2 (IL2)IBA
01/2004 - 01/2001
2CreatinineIBA
11/2003 - 10/2000
2Cathepsin DIBA
04/2003 - 12/2002
2GemcitabineFDA Link
01/2001 - 01/2000
1Bevacizumab (Avastin)FDA Link
12/2012
1CollagenIBA
10/2012
1Prolyl Hydroxylases (Prolyl Hydroxylase)IBA
10/2012
1Azacitidine (5 Azacytidine)FDA Link
04/2012
1Angiogenesis Inducing Agents (Angiogenesis Factor)IBA
01/2012
1Tyrosine Kinase InhibitorsIBA
01/2011
1Protein-Tyrosine Kinases (Tyrosine Kinase)IBA
01/2011
1Trastuzumab (Herceptin)FDA Link
05/2009
1thiamine triphosphorate (TTP)IBA
02/2009
1RNA (Ribonucleic Acid)IBA
12/2008
1Oxaliplatin (Eloxatin)FDA LinkGeneric
07/2008
1Phosphotransferases (Kinase)IBA
12/2007
1Carrier Proteins (Binding Protein)IBA
01/2006
1MetalsIBA
01/2006
1Methotrexate (Mexate)FDA LinkGeneric
11/2005
1Fluorouracil (Carac)FDA LinkGeneric
11/2005
1Cyclophosphamide (Cytoxan)FDA LinkGeneric
11/2005
1Topotecan (Hycamtin)FDA LinkGeneric
05/2005
1Vasopressins (Vasopressin)IBA
01/2005
1StreptavidinIBA
12/2004
1AvidinIBA
12/2004
1Syndecan-1 (Syndecan 1)IBA
12/2004
1Biotin (Vitamin H)FDA Link
12/2004
1liposomal doxorubicin (Doxil)FDA Link
10/2004
1Steroid Receptors (Steroid Receptor)IBA
05/2004
1Biological ProductsIBA
05/2004
1Superoxide DismutaseIBA
01/2004
1AntibodiesIBA
01/2004
1Reactive Oxygen Species (Oxygen Radicals)IBA
01/2004
1InterleukinsIBA
01/2004
1Temozolomide (Temodar)FDA LinkGeneric
01/2004
1EnzymesIBA
01/2004
1Estrogen Receptor betaIBA
01/2004
1Estrogen Receptor alphaIBA
01/2004

Therapy/Procedure

19Drug Therapy (Chemotherapy)
08/2015 - 01/2000
9Therapeutics
08/2015 - 01/2000
4Combination Drug Therapy (Combination Chemotherapy)
12/2007 - 09/2000
3Adjuvant Chemotherapy
05/2009 - 03/2001
2Radiotherapy
10/2003 - 01/2001
1Cytoreduction Surgical Procedures
02/2009
1Treatment Delay
10/2004